161 related articles for article (PubMed ID: 31897812)
1. Healthcare costs associated with breast cancer in Germany: a claims data analysis.
Kreis K; Plöthner M; Schmidt T; Seufert R; Schreeb K; Jahndel V; Maas S; Kuhlmann A; Zeidler J; Schramm A
Eur J Health Econ; 2020 Apr; 21(3):451-464. PubMed ID: 31897812
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach.
Khan SA; Hernandez-Villafuerte K; Hernandez D; Schlander M
Front Public Health; 2022; 10():946544. PubMed ID: 36684975
[TBL] [Abstract][Full Text] [Related]
3. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
Fu AZ; Jhaveri M
J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
[TBL] [Abstract][Full Text] [Related]
4. Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data.
Cheng CY; Datzmann T; Hernandez D; Schmitt J; Schlander M
Int J Cancer; 2021 Nov; 149(10):1744-1754. PubMed ID: 34213799
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
[TBL] [Abstract][Full Text] [Related]
7. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
8. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
[TBL] [Abstract][Full Text] [Related]
9. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study.
Chen HM; Chen JH; Chiang SC; Lin YC; Ko Y
Medicine (Baltimore); 2021 Oct; 100(43):e27567. PubMed ID: 34713830
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
[TBL] [Abstract][Full Text] [Related]
12. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
[TBL] [Abstract][Full Text] [Related]
13. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
[TBL] [Abstract][Full Text] [Related]
14. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
[TBL] [Abstract][Full Text] [Related]
15. The economic impact of disease progression and death in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data.
Park SK; Park JA; Yang SY; Shin JY; Koh H
Curr Med Res Opin; 2020 Nov; 36(11):1825-1833. PubMed ID: 32965131
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
19. Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population.
Shah R; Corman S; Shah A; Kebede N; Nwankwo C
J Med Econ; 2021; 24(1):1221-1230. PubMed ID: 34686073
[TBL] [Abstract][Full Text] [Related]
20. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data.
Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B
Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
